You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Development of Wnt Pathway Inhibitors for Colorectal Cancer

    SBC: Stemsynergy Therapeutic            Topic: NCI

    DESCRIPTION (provided by applicant): StemSynergy Therapeutics Inc. (SSTI) is a biopharmaceutical company focused on the discovery, development, and commercialization of drugs that target pathways fundamental to stem cells and cancer stem cells. The WorldHealth Organization estimates that over 12 million cases of cancer were diagnosed in 2007 and that nearly 8 million cancer patients will die of t ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  2. Computerized Stage-Matched Intervention for Juvenile Offenders

    SBC: Pro-Change Behavior Systems, Inc.            Topic: NIDA

    DESCRIPTION (provided by applicant): Juvenile crime imposes enormous costs on victims, on society, and on juvenile offenders themselves. However, research assessing the efficacy of interventions for young offenders show, on average, only small effects on recidivism, substance abuse, and other behavioral outcomes. A major problem with existing interventions is that they tend to neglect individual d ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  3. EpiVax Phase II SBIR: Preclinical studies of Tregitope Delivery and Mechanism of

    SBC: EPIVAX, INC.            Topic: NIDDK

    DESCRIPTION (provided by applicant): The goal of this Phase II project is to advance the development of novel tolerance-inducing peptides (Tregitopes) to prevent and/or treat Type 1 diabetes (T1D) by optimizing the clinical delivery vehicle and treatment protocol, and by identifying correlates of efficacy in preparation for Phase 1 clinical trials. More than 13,000 children in the U.S. are diagnos ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  4. Virtual Emergency Medical Technician-Basic Training Program

    SBC: ARCHIE MD INC.            Topic: NHLBI

    DESCRIPTION (provided by applicant): ZetrOZ has developed a prototype novel, miniature, portable, high-power, ultrasound system for would healing. Wound healing is a major clinical issue, and can present significant clinical challenges both when wounds areacute--occurring due to trauma, burns, surgery, or due to more chronic health problems. Wound healing is an intricate fibroproliferative respons ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  5. Reduction of Dietary Oxalate

    SBC: CAPTOZYME LLC            Topic: NCCAM

    DESCRIPTION (provided by applicant): Kidney stones are a common and painful human health care problem worldwide. Of all stones developed approximately 75% are composed of calcium oxalate. Urinary oxalate is regarded as a driving force for calcium oxalate stone formation, and absorption of dietary oxalate contributes to 10-70% of urinary oxalate. In fact, roughly 2.4 million Americans (0.75% of the ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  6. Safety and Efficacy of Single-use Cliradex Pads for Ocular Mites

    SBC: BIOTISSUE HOLDINGS INC.            Topic: NEI

    DESCRIPTION (provided by applicant): Demodex mites are microscopic ectoparasites that commonly infest the pilosebaceous unit of the skin. Uncontrolled overgrowth of mites has been implicated in causing papulopustular lesions in the skin, rosacea in the face, and blepharitis in the eye. Blepharitis (lid margin inflammation) associated with mite-harboring cylindrical dandruff in eyelashes is one of ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  7. Extreme-Speed Eigensolver Suite

    SBC: Accelogic, LLC            Topic: 40a

    One of the most important numerical problems in science and engineering is that of finding the eigenvalues and eigenvectors of large-scale matrices. Methods for the solution of these problems, usually called eigensolvers, are fundamental to many industrial and scientific applications ranging from computational chemistry problems to structural design, to other modeling- and simulation- intense disc ...

    SBIR Phase II 2012 Department of Energy
  8. Augmented Reality Simulation for Teaching Medical Students

    SBC: ARCHIE MD INC.            Topic: OD

    DESCRIPTION (provided by applicant): Currently, the physician workforce is aging and average hours worked is falling compared to historical levels. In addition, the physician-to-population ratio is beginning to plateau, and is expected to decline right asthe U.S. elderly (and more medically needy) population is on the rise. Thus, the physician workforce may not be able fulfill the U.S. population ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  9. Novel Polishing Process to Fabricate Ultra Low Thickness Variation Diamond Substrates for Next Generation Beam Tracking Detectors

    SBC: Sinmat Inc            Topic: 45b

    Diamond crystals with small total thickness variation (TTV) and local thickness variation (LTV) values are needed for position sensitive fast particle detectors for particle tracking/timing, and detecting direct/indirect beams. The fabrication of ultra-flat, low surface defectivity diamond detectors represents a major technological challenge. Although current commercial technology can produce 100m ...

    SBIR Phase II 2012 Department of Energy
  10. Amniotic Membrane versus Pericardium in Reducing Glaucoma Drainage Tube Exposure

    SBC: BIOTISSUE HOLDINGS INC.            Topic: NEI

    DESCRIPTION (provided by applicant): Glaucoma drainage devices (GDDs) have widely been used in the treatment of high-risk refractory glaucoma. To avoid tube exposure, which may lead to serious eye infection, the implanted GDD tube must be covered by apatch graft traditionally made of either donor sclera or pericardium. However, these patch grafts still carry a high rate of progressive thinning ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government